Trevi Therapeutics, Inc. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • June 29th, 2023 • Trevi Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 29th, 2023 Company Industry JurisdictionTrevi Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Securities LLC (the “Agent”), as follows: